MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 64 filers reported holding MEI PHARMA INC in Q3 2018. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $25,000 | +47.1% | 10,000 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $17,000 | -66.0% | 10,000 | -50.0% | 0.00% | -66.7% |
Q2 2019 | $50,000 | -18.0% | 20,000 | 0.0% | 0.01% | -18.2% |
Q1 2019 | $61,000 | +15.1% | 20,000 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $53,000 | -38.4% | 20,000 | 0.0% | 0.01% | -31.2% |
Q3 2018 | $86,000 | +8.9% | 20,000 | 0.0% | 0.02% | +6.7% |
Q2 2018 | $79,000 | – | 20,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anson Funds Management LP | 4,610,423 | $1,782,000 | 0.21% |
DAFNA Capital Management LLC | 1,767,146 | $683,000 | 0.18% |
NEA Management Company, LLC | 8,533,072 | $3,299,000 | 0.16% |
Boxer Capital, LLC | 2,913,091 | $1,126,000 | 0.06% |
BVF INC/IL | 3,532,057 | $1,365,000 | 0.06% |
Investmark Advisory Group LLC | 136,000 | $52,000 | 0.05% |
CARLSON CAPITAL L P | 1,150,000 | $445,000 | 0.03% |
Artal Group S.A. | 1,000,000 | $387,000 | 0.02% |
Annandale Capital, LLC | 100,000 | $39,000 | 0.01% |
Sigma Planning Corp | 641,050 | $248,000 | 0.01% |